This inventor holds 4 USPTO granted patents. Top assignee: Massachusetts Institute of Technology. Active years: 2004-2008.
Company Filing History:
Years Active: 2004-2008
Title: The Innovations of Casim A. Sarkar
Introduction
Casim A. Sarkar is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of granulocyte colony-stimulating factor (G-CSF) analogs. With a total of 4 patents to his name, Sarkar's work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Sarkar's latest patents focus on methods of using G-CSF analog compositions. The first patent relates to G-CSF analog polypeptide compositions, which include related nucleic acids, expression constructs, host cells, and processes for recombinant production. This invention introduces novel mutants of G-CSF, utilizing single amino acid substitutions to enhance cellular trafficking of G-CSF and/or G-CSFR. Additionally, pharmaceutical compositions and methods of use are provided. The second patent also pertains to G-CSF analog compositions, detailing methods for screening these analogs designed with amino acid substitutions. This work aims to identify analogs suitable for use as G-CSF replacements or antagonists, with broader applications beyond G-CSF analogs.
Career Highlights
Sarkar is affiliated with the Massachusetts Institute of Technology, where he continues to advance his research in biotechnology. His innovative work has garnered attention in the scientific community, contributing to the understanding and application of G-CSF analogs in medicine.
Collaborations
Some of Sarkar's notable coworkers include Douglas A. Lauffenburger and Bruce Tidor. Their collaborative efforts have further enriched the research environment and fostered advancements in their respective fields.
Conclusion
Casim A. Sarkar's contributions to the field of biotechnology, particularly through his patents on G-CSF analogs, highlight his role as an influential inventor. His work not only enhances our understanding of G-CSF but also opens new avenues for therapeutic applications.